Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy

Management of bone metastases from renal cell carcinoma (RCC) has significantly changed after the era of targeted therapy that improved the overall survival (OS). Surgical decision‐making remains a subject of controversy. We report a case of pelvic bone metastasis from RCC, 2 months after nephrectom...

Descripción completa

Detalles Bibliográficos
Autores principales: Nefiss, Mouadh, Abid, Hichem, Gharbi, Mohamed Amine, Bouzidi, Ramzi, Teborbi, Anis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666916/
https://www.ncbi.nlm.nih.gov/pubmed/36408090
http://dx.doi.org/10.1002/ccr3.6599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666916/
https://www.ncbi.nlm.nih.gov/pubmed/36408090
http://dx.doi.org/10.1002/ccr3.6599

Ejemplares similares